We are live on ! Find out more
PG

Pendal Group Portfolio holdings

AUM $11.6B
1-Year Est. Return 12.87%
This Fund
S&P 500
This Quarter Est. Return
+1.65%
1 Year Est. Return
-12.87%
3 Year Est. Return
+52.75%
5 Year Est. Return
+103.82%
10 Year Est. Return
–
AUM
$12.1B
AUM Growth
+$1.2B
Cap. Flow
+$1.49B
Cap. Flow %
12.26%
Top 10 Hldgs %
30.95%
Holding
675
New
129
Increased
199
Reduced
220
Closed
109

Top Buys

Rank Stock Value
1
BNTX icon
BioNTech
BNTX
+$463M
2
BABA icon
Alibaba
BABA
+$168M
3
UNH icon
UnitedHealth
UNH
+$142M
4
LIN icon
Linde
LIN
+$136M
5
CHKP icon
Check Point Software Technologies
CHKP
+$129M

Top Sells

Rank Stock Value
1
PRAH
PRA Health Sciences, Inc.
PRAH
+$115M
2
MEDP icon
Medpace
MEDP
+$115M
3
ORCL icon
Oracle
ORCL
+$112M
4
MKSI icon
MKS Inc
MKSI
+$99.1M
5
ARMK icon
Aramark
ARMK
+$92.8M

Sector Composition

Rank Sector Weight
1 Technology 20.61%
2 Healthcare 16.66%
3 Financials 15.34%
4 Consumer Discretionary 9.67%
5 Communication Services 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INFO
1
DELISTED
IHS Markit Ltd. Common Shares
INFO
$514M 4.24%
4,406,176
-118,765
-3% -$14M
APTV icon
2
Aptiv
APTV
$12.3B
$504M 4.16%
3,383,722
+314,213
+10% +$48.9M
ACN icon
3
Accenture
ACN
$106B
$491M 4.05%
1,534,825
-149,008
-9% -$48.5M
ICLR icon
4
Icon
ICLR
$13.7B
$443M 3.66%
1,692,148
+32,095
+2% +$7.8M
MGA icon
5
Magna International
MGA
$18.8B
$401M 3.31%
5,332,730
+542,901
+11% +$44.7M
BNTX icon
6
BioNTech
BNTX
$23.5B
$397M 3.28%
+1,455,825
New +$463M
PM icon
7
Philip Morris
PM
$309B
$293M 2.41%
3,086,207
-119,056
-4% -$12M
LIN icon
8
Linde
LIN
$236B
$243M 2.01%
829,619
+447,052
+117% +$136M
TMO icon
9
Thermo Fisher Scientific
TMO
$214B
$235M 1.94%
411,422
+185,074
+82% +$102M
LBTYK icon
10
Liberty Global Class C
LBTYK
$3.5B
$229M 1.89%
7,780,465
+3,945,011
+103% +$110M
ATO icon
11
Atmos Energy
ATO
$29.7B
$222M 1.83%
2,514,877
-48,352
-2% -$4.68M
SRE icon
12
Sempra
SRE
$58.1B
$220M 1.82%
3,483,592
+125,026
+4% +$8.25M
ICE icon
13
Intercontinental Exchange
ICE
$87.2B
$217M 1.79%
1,890,544
+386,234
+26% +$45.8M
PGR icon
14
Progressive
PGR
$128B
$216M 1.78%
2,384,757
+18,167
+0.8% +$1.73M
HSIC icon
15
Henry Schein
HSIC
$9.78B
$209M 1.72%
2,739,522
+1,159,051
+73% +$89.2M
EXC icon
16
Exelon
EXC
$48.1B
$205M 1.7%
5,957,793
-1,503,438
-20% -$51.4M
LHX icon
17
L3Harris
LHX
$55.4B
$189M 1.56%
858,744
-155,301
-15% -$35.3M
MTB icon
18
M&T Bank
MTB
$36.3B
$186M 1.54%
1,247,067
+320,485
+35% +$44.4M
ORCL icon
19
Oracle
ORCL
$339B
$185M 1.53%
2,121,143
-1,273,079
-38% -$112M
MSFT icon
20
Microsoft
MSFT
$2.9T
$164M 1.35%
582,390
-163,952
-22% -$47.7M
IBN icon
21
ICICI Bank
IBN
$107B
$142M 1.17%
8,191,997
+1,999,043
+32% +$37.5M
UNH icon
22
UnitedHealth
UNH
$382B
$134M 1.11%
343,950
+343,233
+47,871% +$142M
TEAM icon
23
Atlassian
TEAM
$26.5B
$131M 1.08%
335,188
-133,828
-29% -$44.7M
A icon
24
Agilent Technologies
A
$39.6B
$130M 1.07%
826,389
-154,559
-16% -$25M
V icon
25
Visa
V
$677B
$127M 1.05%
571,905
+521,397
+1,032% +$122M
1
2 3 4 5

Similar funds

RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return
GG
Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return
AIM
Allstate Investment Management Chicago, Illinois $3.29B AUM
AAM
Abeille Asset Management France $2.82B AUM 15.24% 1-Year Est. Return
PCA
Personal Capital Advisors Redwood City, California $20.6B AUM 13.65% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
GJIC
Gamble Jones Investment Counsel Pasadena, California $1.33B AUM 11.55% 1-Year Est. Return
SBL
Sargent Bickham Lagudis Boulder, Colorado $1.22B AUM 14.94% 1-Year Est. Return

Pendal Group's Q3 2021 Portfolio in Review

As of Q3 2021, Pendal Group held 675 positions worth $12.1B, up 11% from $10.9B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Pendal Group deployed $1.49B of net new capital in Q3 2021, opening 129 new positions and adding to 199 existing holdings. Its largest new stake was BioNTech: 1,455,825 shares worth $397M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Medpace, an estimated $115M trimmed.

  • Pendal Group's largest Q3 2021 buy was BioNTech: 1,455,825 shares worth $397M.
  • Pendal Group added most to Alibaba in Q3 2021, an estimated $168M increase.
  • Pendal Group's biggest Q3 2021 reduction was Medpace, cutting an estimated $115M.
  • Pendal Group fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $115M.
  • Pendal Group's ten largest holdings make up 31% of its $12.1B portfolio in Q3 2021.
  • Pendal Group opened 129 new positions and closed 109 in Q3 2021.
  • Pendal Group's portfolio value rose 11% quarter-over-quarter to $12.1B.

Based on Pendal Group's 13F filing for Q3 2021, filed 5 Nov 2021.